Clinical Trial Update: Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effects of levosimendan in patients eligible for aortic valve replacement with left ventricular hypertrophy; study terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Dysfunction
• Left Ventricular Hypertrophy

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: University of Aarhus | Conditions: Diastolic Dysfunction, Left Ventricular Hypertrophy | Phase 4 | Status: TERMINATED | Results posted: 2018-12-03